Hindustan Times ST (Mumbai) - HT Navi Mumbai Live - - NAVI MUMBAI - Tas­neem Kausar ht­for­nav­i­mum­bai@hin­dusi­tan­

Sub­hash Raosa­heb Tope, 65, a busi­ness­man who was also ac­tive in pol­i­tics, had been com­plain­ing of itch­ing and gen­eral weak­ness for the past six months. Ow­ing to his health con­di­tion, he had to dis­con­tinue his work.

He also had to deal with prob­lems of hy­per­ten­sion, di­a­betes and a chronic kid­ney dis­ease for the past 30 years.

Tope was also re­ported to have had in­ter­mit­tent low-grade fever and jaun­dice over the last two months.

His was a known case of liver cir­rho­sis, hy­per­ten­sion, di­a­betes mel­li­tus with nephropa­thy.

He put a stop to his drink­ing and to­bacco con­sump­tion when he was di­ag­nosed with liver cir­rho­sis. His con­di­tion grad­u­ally de­te­ri­o­rated over the last five years.

Dr Pradeep Ma­ha­jan, stem cell trans­plant sur­geon, StemRx Hos­pi­tal, Airoli said, “Af­ter com­plete clin­i­cal, ra­di­o­log­i­cal and haema­to­log­i­cal in­ves­ti­ga­tions, a treat­ment pro­to­col com­pris­ing two ses­sions of cel­lu­lar ther­apy over a pe­riod of 1-2 months was made. The goal of cel­lu­lar ther­apy was to bring about an over­all im­prove­ment in each sys­temic con­di­tion thereby im­prov­ing the pa­tients’ qual­ity of life. ”

“Symp­to­matic re­lief from itch­ing and weak­ness was ob­served within the first week fol­low­ing cel­lu­lar ther­apy. Dur­ing the fol­low-up, haema­to­log­i­cal and ra­di­o­log­i­cal in­ves­ti­ga­tions were re­peated which re­vealed an im­prove­ment in liver and re­nal func­tion pa­ram­e­ters. Re­duc­tion in cre­a­ti­nine lev­els was noted. Blood glu­cose lev­els were also found to be within nor­mal lim­its.” adds Ma­ha­jan.

Tope said, “The stem cell trans­plant surgery gave me a se­cond chance to live the life which I missed be­cause of my un­healthy habits.” 10 me­tres on both sides of Airoli NMMC pub­lic hos­pi­tal at Sec­tor 3 will be a no-park­ing zone.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.